Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Pheochromocytoma
Stage/Subtype:  metastatic pheochromocytoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-4 of 4 for your search:
Start Over
A Study Evaluating Ultratrace Iobenguane I 131 (MIBG) in Patients With Malignant Pheochromocytoma/Paraganglioma
Phase: Phase II
Type: Treatment
Age: 12 and over
Trial IDs: MIP-IB12B, NCI-2010-01344, NCT00874614
Axitinib in Treating Patients with Pheochromocytoma or Paraganglioma This is Metastatic, Recurrent or Cannot Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-C-0001, NCI-2014-02504, P11898, NCT01967576
Iobenguane I 131 in Treating Patients With Refractory Neuroblastoma or Metastatic Pheochromocytoma
Phase: No phase specified
Type: Supportive care, Treatment
Age: 1 and over
Trial IDs: 2012LS107, NCI-2013-01933, NCT01850888
Cabozantinib-s-malate in Treating Patients with Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 2014-0081, NCI-2014-02607, NCT02302833
Start Over